RESUMEN

Myelomatous pleural effusion (MPE) is an uncommon clinical entity and occurs in less than 1% of all patients with multiple myeloma. MPE indicates a progression of disease, therefore is associated with a poor prognosis and estimated median survival of <3 months. Treatment of MPE is challenging, and the data regarding the role of novel agents lack in the literature. Herein, we report a relapsed IgA myeloma case of a patient presenting with MPE, who was treated with pomalidomide with a very good partial response.

Asunto(s)

Dexametasona/uso terapéutico , Mieloma Múltiple/complicaciones , Derrame Pleural Maligno/terapia , Talidomida/análogos & derivados , Drenaje , Disnea/etiología , Humanos , Masculino , Persona de Mediana Edad , Células Plasmáticas/patología , Derrame Pleural Maligno/diagnóstico por imagen , Radiografía Torácica , Talidomida/uso terapéutico , Toracocentesis , Resultado del Tratamiento